Martin Plambech

Martin Plambech is the CEO of Biosyntia, which develops novel fermentation processes. Prior to Biosyntia, he was responsible for business development within Animal Health & Nutrition, Novozymes. He has also worked for Boston Consulting Group in Europe & Australia and been a First Lieutenant in the Danish Army. He holds a M.Sc. in Finance & Strategic Management from Copenhagen Business School.

SynBioBeta is the leading community of entrepreneurs, investors, policymakers and enthusiasts devoted to the responsible growth of the synthetic biology field. We’re dedicated to telling the stories of the field and companies involved, building their networks, and helping them grow.